Bioarctic Ab (BRCTF)

$24.80 +1.93 (8.42%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 200
Avg Vol 450
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 100%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additiona...

Industry: Biotechnology
Sector: Healthcare
Phone: 46 86 95 69 30
Address:
Warfvinges vag 35, Stockholm, Sweden
SigmundOoze
SigmundOoze Feb. 20 at 6:57 PM
$BRCTF Something is brewing... I'm glad I have held a small block for almost a year...
0 · Reply
cielo1
cielo1 Jan. 7 at 5:33 PM
$IFRX $BRCTF Bioarctic still has not received their marketing authorization. https://www.bioarctic.com/en/chmp-issues-positive-recommendation-for-approval-of-lecanemab-in-the-eu/ let us see a deal like this with ROCHE and IFRX https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/
0 · Reply
Thorsunderarm
Thorsunderarm Dec. 19 at 1:29 PM
$BRCTF bullish malakas
0 · Reply
Juststartingout14
Juststartingout14 Aug. 25 at 12:34 AM
$BRCTF just want everyone to know this before so you can make a qualified decision https://www.alzheimersresearchuk.org/news/newly-licensed-alzheimers-drug-lecanemab-not-available-on-nhs/
0 · Reply
Juststartingout14
Juststartingout14 Aug. 24 at 9:37 PM
$BRCTF UK not taking it on
0 · Reply
SigmundOoze
SigmundOoze Aug. 23 at 3:25 PM
$ESALY $BRCTF finally- something good moving these stocks... https://www.bioarctic.com/en/leqembi-lecanemab-authorized-for-early-alzheimers-disease-in-great-britain/
0 · Reply
SigmundOoze
SigmundOoze May. 2 at 8:15 PM
$BRCTF surprised to see no activity here... This, I believe is a moonshot with legs to run on any positive news...
0 · Reply
stick_to_stocks
stick_to_stocks Aug. 30 at 7:34 PM
$DARE sold 20% of my shares. I said I am long (now time frame is 4 y since last year was 5). The reason for selling is that the continuous delayed milestones have reach the point in which are trully affecting company financing. The other reason is the disrespectul offering we have seen today. Still believe in the products abd the company. I am -35%, surprisingly my two highest risky players $AXSM and $BRCTF way compensate the losses I am taking from Dare. Hopefully things get better, if so, I may put the 20% back. From now I will be keeping an eye on the highly in debt but huge potential $BNGO
2 · Reply
Latest News on BRCTF
No data available.
SigmundOoze
SigmundOoze Feb. 20 at 6:57 PM
$BRCTF Something is brewing... I'm glad I have held a small block for almost a year...
0 · Reply
cielo1
cielo1 Jan. 7 at 5:33 PM
$IFRX $BRCTF Bioarctic still has not received their marketing authorization. https://www.bioarctic.com/en/chmp-issues-positive-recommendation-for-approval-of-lecanemab-in-the-eu/ let us see a deal like this with ROCHE and IFRX https://www.bioarctic.com/en/bioarctic-announces-global-license-agreement-with-bristol-myers-squibb-for-bioarctics-pyroglutamate-amyloid-beta-antibody-program/
0 · Reply
Thorsunderarm
Thorsunderarm Dec. 19 at 1:29 PM
$BRCTF bullish malakas
0 · Reply
Juststartingout14
Juststartingout14 Aug. 25 at 12:34 AM
$BRCTF just want everyone to know this before so you can make a qualified decision https://www.alzheimersresearchuk.org/news/newly-licensed-alzheimers-drug-lecanemab-not-available-on-nhs/
0 · Reply
Juststartingout14
Juststartingout14 Aug. 24 at 9:37 PM
$BRCTF UK not taking it on
0 · Reply
SigmundOoze
SigmundOoze Aug. 23 at 3:25 PM
$ESALY $BRCTF finally- something good moving these stocks... https://www.bioarctic.com/en/leqembi-lecanemab-authorized-for-early-alzheimers-disease-in-great-britain/
0 · Reply
SigmundOoze
SigmundOoze May. 2 at 8:15 PM
$BRCTF surprised to see no activity here... This, I believe is a moonshot with legs to run on any positive news...
0 · Reply
stick_to_stocks
stick_to_stocks Aug. 30 at 7:34 PM
$DARE sold 20% of my shares. I said I am long (now time frame is 4 y since last year was 5). The reason for selling is that the continuous delayed milestones have reach the point in which are trully affecting company financing. The other reason is the disrespectul offering we have seen today. Still believe in the products abd the company. I am -35%, surprisingly my two highest risky players $AXSM and $BRCTF way compensate the losses I am taking from Dare. Hopefully things get better, if so, I may put the 20% back. From now I will be keeping an eye on the highly in debt but huge potential $BNGO
2 · Reply